ArticleACS infectious diseases2017

Benzimidazole-Based FabI Inhibitors: A Promising Novel Scaffold for Anti-staphylococcal Drug Development.

Tina L Mistry et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.